Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Topical tofacitinib is effective and safe for treating alopecia areata.

Entadfi, a mix of finasteride and tadalafil, is used for BPH.

Ritlecitinib may cause serious side effects like blood clots in alopecia areata patients.

The document concludes that measuring γ-glutamyl transpeptidase activity is more accurate with a higher substrate concentration and using diluted acetic acid to stop the reaction.

The ABI1 gene contributes to prostate cancer progression and treatment resistance.

New method accurately measures finasteride in medicine using NQS.

Properly administered testosterone therapy is safe and effective but often not covered by insurance.

Tofacitinib was found to be a safe and effective treatment for hair regrowth in patients with alopecia areata.

Method accurately measures finasteride and tamsulosin in combined drug form.

Tofacitinib effectively regrows hair in alopecia areata but may need continuous use.

MT-DADMe-ImmA can selectively kill head and neck cancer cells without harming normal cells.

Clq deficiency is linked to systemic lupus erythematosus symptoms.

Tideglusib with a bacterial cellulose hydrogel improves wound healing in rats.

Pexidartinib often causes liver issues and fatigue, especially in women.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

Terminalia bellirica extracts effectively promote hair regrowth and treat androgenetic alopecia.

QR678 Neo® is a safe and effective treatment for hair loss in men and women.

PCA hydrogel promotes hair growth by enhancing blood vessel formation and hair follicle stem cell activity.

RTA 408 cream protects mice from radiation skin damage.

GT20029 showed some hair growth improvement, but longer studies are needed for better results.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Quaternary ammonium iminofullerenes help maize roots grow better under stress by reducing oxidative damage.

Tofacitinib is a promising and safe treatment for moderate to severe alopecia areata.

Bexxar is highly effective as a first treatment for non-Hodgkin's lymphoma, with most patients alive and many in remission after eight years.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Loss of TET2 increases the risk of skin and oral cancer.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.